| 44.19 Delayed Data As of Jul 15 |  -0.08 / -0.18%Today’s Change | 43.81 Today|||52-Week Range 63.69 | -14.99% Year-to-Date |
| Previous close | 44.27 |
| Today’s open | 44.28 |
| Day’s range | 44.05 - 44.57 |
| Volume | 8,885,443 |
| Average volume (3 months) | 15,332,887 |
| Market cap | -- |
| Earnings growth (last year) | +393.92% |
| Earnings growth (this year) | +4.58% |
| Earnings growth (next 5 years) | +5.50% |
| Revenue growth (last year) | +8.59% |
| P/E ratio | 14.1 |
| Price/Sales | 3.77 |
| Price/Book | -- |
| Today’s change | Today’s % change | |
|---|---|---|
| CELGCelgene | -0.17 | -0.18% |
| NVONovo Nordisk | +0.11 | +0.23% |
| TAKTakeda Pharmaceutica... | +0.20 | +1.12% |
| AGNAllergan | +0.23 | +0.14% |
| Next reporting date | July 25, 2019 |
| EPS forecast (this quarter) | $1.06 |
| Annual revenue (last year) | $22.6B |
| Annual profit (last year) | $4.9B |
| Net profit margin | 21.81% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
Chairman & Chief Executive Officer Giovanni Caforio |
CFO, EVP & Head-Global Business Operations Charles A. Bancroft |
Corporate headquarters New York, New York |
